(World Journal of Gastroenterology) Helicobacter pylori has been accepted as an important pathogen inducing gastric cancer.
A research group from Taiwan investigated optimal intervention point of Celecoxib, to inhibit H. pylori-associated gastric carcinogenesis in Mongolian gerbils.
They found that short-term use resulted in less severe inflammation and inhibited the invasion degree of gastric cancer.
Therefore, Celecoxib could be used in the later stages of H. pylori infection to achieve safe and effective chemoprevention of gastric adenocarcinoma.
Popular products
Post new comment